In patients with anxiety/depression symptoms, there were 25 (45.5%) cases of steroid resistance, 8 (20%) cases of AZA/6-MP resistance, and 9 (19.6%) cases of primary nonresponse to anti-TNF drugs, all of which were higher than those without anxiety/depression symptoms. The gene discussed is TNF; the disease is depressive symptom measurement.